Circular RNA (circRNA) is a key regulator in the development and progression of human cancers. Previous studies confirmed circRNA-0008717 (circABCB10)
| INTRODUCTION
Lung cancer is a leading cause of death and is becoming more prevalent worldwide. 1 The most frequent type of lung cancer is nonsmall cell lung cancer (NSCLC, approximately 85% of all lung cancers). Low-income and middleincome countries now account for more than 50% of lung cancer deaths each year. Although treatments are improving, the 5-year survival rate is still only 17% for NSCLC. 2, 3 Therefore, a better understanding of the molecular mechanisms associated with NSCLC pathogenesis is critical to the development of effective diagnostic and therapeutic approaches, which may lead to the identification of novel biomarkers and treatment targets for NSCLC and possibly to the development of personalized therapies for individual NSCLC patients in the future.
However, the biological functions of circRNAs in human diseases are still unclear, especially in cancer pathogenesis. Recently, studies have found that several circRNAs possess microRNA (miRNA) binding sites and can regulate miRNA downstream targets by sponging and arresting the activity of miRNAs. [6] [7] [8] One study found that circRNA-0008717 (circABCB10) was upregulated in osteosarcoma, suggesting its use as a prognostic biomarker for osteosarcoma patients. 9 The circABCB10 is cyclized from part of the exon region in the ABCB10 gene, but its role in NSCLC remains unclear. Therefore, in the current study, we compared circABCB10 expression between normal lung epithelial cells and lung cancer cell lines. The effects of circABCB10 expression on cell migration and proliferation of lung cancer cell lines were also investigated. Bioinformatics analysis and fluorescein reporting experiments suggested an interaction between circABCB10, miR-1252, and Forkhead box 2 (FOXR2). We found that circABCB10 played an oncogenic role in NSCLC by sponging miR-1252 to increase FOXR2 synthase expression and consequently promote NSCLC progression. Therefore, circABCB10 may serve as a useful biomarker for prognosis predictions and as a potential therapeutic target for NSCLC patients.
| MATERIALS AND METHODS

| Ethics statement
All animal experiments were approved and performed according to the guidelines of the Ethics Committee of Zhongshan Hospital of Fudan University, Shanghai, China. All surgical procedures were performed under anesthesia, and every effort was made to minimize suffering.
| Cell culture and transfection
Breast cancer cell lines (A549, H1975, PC9, H1299, and H1650) and normal human lung epithelial cells (BEAS-2B) were purchased from the American Type Culture Collection (Manassas, VA) and cultured in Roswell Park Memorial Institute Medium 1640 (Invitrogen, Carlsbad, CA) containing 10% fetal bovine serum (FBS; Gibco, Grand Island, NY) with 100 IU/mL of penicillin and 100 μg/mL of streptomycin at 37°C in 5% CO 2 .
Small interfering RNA (siRNA) against hsa_circ_0008717 (circABCB10; 5′-TAGAAGACCATGGGGGATGTCAAGAG-CATCCCCCATGGTCTTCTATTTTTT-3′), miR-1252 mimic (5′-AGAAGGAAAUUGAAUUCAUUUA-3′), and miR-1252 inhibitor (synthesized by GenePharma, Shanghai, China) were transfected into lung cancer cells using Lipofectamine 2000 Reagent (Invitrogen).
For circABCB10 overexpression, circABCB10 overexpression vector was constructed into pCDNA3.0 and transfected into BEAS-2B cell with the help with Lipofectamine 2000.
| Bioinformatics analysis
The hsa_circ_0008717 (circABCB10)-miRNA target gene prediction was performed using the https://circinteractome. nia.nih.gov/ website. The miR-1252-mRNA target gene prediction was performed using the http://www.targetscan. org/vert_71/ website. 
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| Transwell migration assays
Cell migration was analyzed using Transwell chambers (Corning, New York, NY) according to the manufacturer's protocol. After incubation for 24 hours, cells on the upper surfaces of the Transwell chambers were removed with cotton swabs, and the cells located on the lower surfaces were fixed in methanol for 10 minutes, followed by staining with crystal violet. The stained cells were photographed and counted in five randomly selected fields.
| Luciferase reporter assay
For luciferase reporter assays, wild-type (wt) and mutant (mut) promoters of circABCB10 and wt and mut sequences from the 3′-untranslated region (3′-UTR) of FOXR2 were synthesized and inserted into pGL3-basic vectors (GeneCreat, Wuhan, China). The pGL3-basic-circABCB10-wt/ mut vectors, pGL3-basic-FOXR2-wt/mut vectors, and pcDNA3.1-c-Myb vectors were cotransfected with pRL-TK into HEK293T cells using Lipofectamine 2000. For circABCB10 and miR-1252 luciferase reporter assays, circABCB10 and FOXR2 3′-UTR sequences containing wt or mutated miR-1252 binding sites were synthesized and inserted into the pmirGLO luciferase vector (Gene-Creat) and then cotransfected with miR-1252 mimics into HEK293T cells using Lipofectamine 2000. Cells were harvested 48 hours after transfection, and luciferase activity was detected with the dual-luciferase reporter assay system (Promega, Madison, WI). Relative luciferase activity was normalized to the Renilla luciferase internal control.
| Xenografts in mice
A549 cells were stably infected with or without circABCB10 silencing vectors. A total of 5 × 10 6 viable cells were injected into the right flanks of nude mice as described previously. 10 Tumor sizes were measured using a vernier caliper every 5 days from the fifth day after injection, and tumor volume was calculated using the following formula: volume = 1/2 × length × width 2 . At 30 days after implantation, mice were euthanized for quantitative reverse transcription-polymerase chain reaction (qRT-PCR) and Western blot analyses.
| Quantitative reverse transcription-polymerase chain reaction
RNA was extracted from tissues or cultured cells with TRIzol reagent according to the manufacturer's protocol (Life Technologies, Scotland, UK). Reverse transcription of 200 ng of total RNA was performed in a final volume of 10 μL using random primers and standard conditions with the Prime Script RT Master Mix (Applied Biosystems, Foster City, CA). qRT-PCR was performed using the SYBR Select Master Mix (Applied Biosystems) with 0.5 μL of complementary DNA (cDNA) on the ABI7300 system (Applied Biosystems) according to the manufacturer's instructions. We used glyceraldehyde 3-phosphate dehydrogenase (GAPDH) or U6 as internal controls. Relative transcription alterations were evaluated using the 2 C −ΔΔ t method as previously described. 9 
| Western blot analysis
Protein was extracted from cells or tissues using RIPA lysis buffer (Applied Biosystems) and subjected to Western blot analysis as described previously. 11 Anti-FOXR2 and anti-GAPDH antibodies were supplied by Cell Signaling Technology (Beverly, MA). All antibodies were used according to the manufacturer's protocol, and immunoreactivity was visualized using a chemiluminescence detection kit (ECL Western Blotting Substrate; Dongguan Biotech, Shandong, China).
| Statistical analysis
Data were analyzed using the SPSS software package (IBM, Armonk, NY). Statistical significance was determined with the Student t test or analysis of variance, and P < 0.05 was considered statistically significant.
3 | RESULTS
| Knockdown of circABCB10 suppressed NSCLC cell proliferation and migration
The qRT-PCR detection found that circABCB10 was increased in lung cancer cell lines, including the A549, PC9, H1299, H1975, and H1650 cell lines when compared with normal BEAS-2B lung epithelial cells, with the highest expression in A549 and PC9 cells ( Figure 1A) . Consequently, A549 and PC9 cells were selected for the following experiment. To determine if circABCB10 played a role in lung cancer cell proliferation and migration, siRNA against circABCB10 was constructed and transfected into A549 and PC9 cells. The qRT-PCR results showed that circABCB10 expression was decreased after knockdown of circABCB10 for 48 hours compared with the negative control (NC) or nontransfected control cells ( Figure 1B ). CCK8 assays showed that knockdown of circABCB10 suppressed cell proliferation in both A549 and PC9 cells ( Figure 1C and 1D ). Transwell analysis found that downregulating circABCB10 expression decreased the migratory capacity of both A549 and PC9 cells ( Figure 1E and 1F), suggesting that circABCB10 plays a role in lung cancer cell proliferation and migration.
| Overexpression circABCB10
promotion BEAS-2B cell proliferation and migration
To identify if circABCB10 has an opposite effect on low expressed cell, circABCB10 overexpression vector was constructed and transfected into BEAS-2B cells. The results show that after transfected with circABCB10 overexpression vector for 48 hours, the expression of circABCB10 was significantly increased compared with the NC group ( Figure. 2A ). CCK8 assays showed that overexpression circABCB10 promotion cell proliferation in BEAS-2B cells ( Figure 2B ). Transwell analysis found that upregulating circABCB10 expression increased the migratory capacity of BEAS-2B cells ( Figure 2C ), which confirmed that circABCB10 plays a promotion effect in cell proliferation and migration.
| MiR-1252 was the target of circABCB10
Increasing evidence has indicated that there is novel functional crosstalk between circRNAs and miRNAs. 6 Therefore, in this study, we analyzed and predicted the interaction between circRNAs and miRNAs using a bioinformatics analysis website. The results showed TIAN ET AL.
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that miR-1252 was a potential target of circABCB10.
To prove this prediction, we conducted luciferase reporter assays ( Figure 3A ) and showed that miR-1252 overexpression significantly inhibited luciferase activity of the circABCB10-wt reporter in both A549 and PC9 cells ( Figure 3B and 3C) , indicating a direct interaction between circABCB10 and miR-1252. The qRT-PCR assays showed that knockdown of circABCB10 promoted miR-1252 expression in both A549 and PC9 cells ( Figure 3D ), suggesting that circABCB10 could sponge miR-1252.
| CircABCB10 promoted FOXR2 expression by sponging miR-1252
Our bioinformatics analysis further suggested that miR-1252 could interact with the 3′-UTR of FOXR2 ( Figure 4A ). In confirmation, luciferase reporter assays showed that Figure 4D and 4E) and demonstrated that circABCB10 knockdown also decreased FOXR2 mRNA and protein expression in both A549 and PC9 cells ( Figure 4F and 4G) . The qRT-PCR experiments showed that circABCB10 silencing significantly suppressed FOXR2 expression, whereas inhibition of miR-1252 rescued FOXR2 levels in both A549 and PC9 cells ( Figure 4H ). CCK8 analysis found that miR-1252 inhibitor treatment reversed the inhibition of cell proliferation induced by circABCB10 silencing in both A549 and PC9 cells ( Figure 4I and 4J) . Transwell analysis also found that downregulation of miR-1252 rescued the loss of migration induced by circABCB10 silencing in both A549 and PC9 cells ( Figure 4K and 4J) . These results suggested that circABCB10 promoted FOXR2 expression by sponging miR-1252, which inhibited lung cancer cell proliferation and migration. D, E, The miR-1252 overexpression suppressed FOXR2 expression at both the mRNA and protein levels in both A549 and PC9 cells. F, G, The circABCB10 knockdown suppressed FOXR2 expression at both the mRNA and protein levels in both A549 and PC9 cells. H, FOXR2 expression was rescued by transfection with an miR-1252 inhibitor in A549 and PC9 cells. I, J, Cell proliferation was determined by CCK8 assays in A549 and PC9 cells. K, L, Transwell assays were used to measure cell migration of A549 and PC9 cells. Each experiment was repeated at least three times; **P < 0.01 and ***P < 0.001. CCK8, Cell Counting Kit-8; FOXR2, Forkhead box 2; GAPDH, glyceraldehyde 3-phosphate dehydrogenase; mRNA, messenger RNA; mut, mutant; NC, negative control; 3′-UTR, 3′-untranslated region; wt, wild type
| Knockdown circABCB10 inhibited lung cancer growth in vivo
Finally, we sought to analyze the effects of circABCB10 on tumor growth in vivo. We performed a xenograft experiment by injecting A549 cells into nude recipient mice. Tumor size was measured and calculated every 5 days. The results show that circABCB10 knockdown significantly inhibited tumor growth ( Figure 5A ). Furthermore, after 30 days postinjection, we measured tumor weights and found that circABCB10 silencing led to smaller tumors ( Figure 5B ). The qRT-PCR detection found that the expression of miR-1252 was increased more in tumor tissues from the circABCB10-silenced group than that in the NC group ( Figure 5C ). Western blot analyses revealed that FOXR2 expression in tumor tissues from the circABCB10-silenced group was decreased when compared with the NC group ( Figure 5D ). and even NSCLC. 19 Knockdown of FOXR2 suppressed | 3771 tumorigenesis, growth, and metastasis. 19 In the current study, we found that overexpression of miR-1252 suppressed FOXR2 expression. Silencing circABCB10 suppressed FOXR2 expression, suggesting that circABCB10 expression promoted FOXR2 by sponging miR-1252. Silencing of miR-1252 reversed circABCB10 knockdowninduced proliferation and inhibited migration of lung cancer cells by promoting FOXR2 expression, which suggested that circABCB10 promoted FOXR2-mediated NSCLC proliferation and migration by regulating miR-1252. Our in vivo studies also confirmed that knockdown of circABCB10 suppressed tumor growth. In summary, our study has for the first time to our knowledge investigated the role of circABCB10 and identified it as an oncogene in NSCLC. Our findings demonstrated that circABCB10 contributed to NSCLC progression by enhancing FOXR2 expression via sponging of miR-1252, suggesting that circABCB10 may be a potential target for NSCLC therapy.
| DISCUSSION
